Chrome Extension
WeChat Mini Program
Use on ChatGLM
VIPCreated with Sketch.

Real-World Study of Osimertinib in Korean Patients with Epidermal Growth Factor Receptor T790M Mutation-Positive Non-Small Cell Lung Cancer.

Jang Ho Lee,Eun Young Kim,Cheol-Kyu Park,Shin Yup Lee,Min ki Lee,Seong‐Hoon Yoon,Jeong Eun Lee,Sang Hoon Lee,Seung Joon Kim,Sung Yong Lee,Jun Hyeok Lim,Tae-Won Jang,Seung Hun Jang,Kye Young Lee,Seung Hyeun Lee,Sei Hoon Yang,Dong Won Park,Chan Kwon Park,Hye Seon Kang,Chang Dong Yeo,Chang-Min Choi,Jae Cheol Lee

Cancer research and treatment（2023）

Cited 2|Views44
No score
Abstract
Osimertinib demonstrated its clinical effectiveness and survival benefit for EGFR T790M mutation-positive in Korean patients with no new safety signals.
More
Translated text
Key words
EGFR T790M,Non–small cell lung cancer,Osimertinib,Real-world efficacy
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined